about
Genprex Inc is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Its technologies are designed to administer disease-fighting genes to provide new therapies for large patient po...
Read More
0.87
0.01
(1.16%)
224.0K
XNAS Volume
XNAS 08 May, 2026 5:30 PM (EDT)
Board Meeting
The next board meeting for Genprex Inc is on 12 May 2026 for the purpose of Genprex Inc First Quarter Earnings Results for 2026
See details
Not Eligible
Expensive Valuation
Technically Bearish
Genprex Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..